72 related articles for article (PubMed ID: 8073816)
21. Activator protein 1 DNA binding activity is decreased in lesional psoriatic skin compared with nonlesional psoriatic skin.
Johansen C; Kragballe K; Rasmussen M; Dam TN; Iversen L
Br J Dermatol; 2004 Sep; 151(3):600-7. PubMed ID: 15377346
[TBL] [Abstract][Full Text] [Related]
22. Serum and tissue angiotensin converting enzyme in patients with psoriasis.
Huskić J; Mulabegović N; Alendar F; Ostojić L; Ostojić Z; Simić D; Milicević R; Naletilić M
Coll Antropol; 2008 Dec; 32(4):1215-9. PubMed ID: 19149231
[TBL] [Abstract][Full Text] [Related]
23. The presence of anti-Fc gamma receptor autoantibodies is related to the clinical presentation of primary Sjögren's syndrome.
Lamour A; Le Corre R; Pennec YL; Youinou P
J Rheumatol; 1995 Dec; 22(12):2241-5. PubMed ID: 8835556
[TBL] [Abstract][Full Text] [Related]
24. Elevated interleukin-18 protein expression in early active and progressive plaque-type psoriatic lesions.
Companjen A; van der Wel L; van der Fits L; Laman J; Prens E
Eur Cytokine Netw; 2004; 15(3):210-6. PubMed ID: 15542445
[TBL] [Abstract][Full Text] [Related]
25. Psoriatic lesional skin exhibits an aberrant expression pattern of interferon regulatory factor-2 (IRF-2).
van der Fits L; van der Wel LI; Laman JD; Prens EP; Verschuren MC
J Pathol; 2003 Jan; 199(1):107-14. PubMed ID: 12474233
[TBL] [Abstract][Full Text] [Related]
26. Ethanol enhances the IFN-gamma, TGF-alpha and IL-6 secretion in psoriatic co-cultures.
Ockenfels HM; Keim-Maas C; Funk R; Nussbaum G; Goos M
Br J Dermatol; 1996 Nov; 135(5):746-51. PubMed ID: 8977675
[TBL] [Abstract][Full Text] [Related]
27. The role of heparin-binding EGF-like growth factor and amphiregulin in the epidermal proliferation of psoriasis in cooperation with TNFalpha.
Yoshida A; Kanno H; Watabe D; Akasaka T; Sawai T
Arch Dermatol Res; 2008 Jan; 300(1):37-45. PubMed ID: 17960400
[TBL] [Abstract][Full Text] [Related]
28. Influence of systemic cyclosporin A on interleukin-2 and epidermal growth factor receptor expression in psoriatic skin lesions.
Horroccks A; Ormerod AD; Duncan JI; Thomson AW
Clin Exp Immunol; 1989 Nov; 78(2):166-71. PubMed ID: 12412743
[TBL] [Abstract][Full Text] [Related]
29. Vascular endothelial growth factor in psoriasis: an indicator of disease severity and control.
Nofal A; Al-Makhzangy I; Attwa E; Nassar A; Abdalmoati A
J Eur Acad Dermatol Venereol; 2009 Jul; 23(7):803-6. PubMed ID: 19309427
[TBL] [Abstract][Full Text] [Related]
30. Evaluation of cytokine serum levels in patients with plaque-type psoriasis.
Roussaki-Schulze AV; Kouskoukis C; Petinaki E; Klimi E; Zafiriou E; Galanos A; Rallis E
Int J Clin Pharmacol Res; 2005; 25(4):169-73. PubMed ID: 16402633
[TBL] [Abstract][Full Text] [Related]
31. Ultrastructural findings and tumor necrosis factor-alpha and intercellular adhesion molecule-1 expression in psoriasis patients before and after oral cyclosporin A therapy.
Eşrefoğlu M; Gül M; Seyhan M
Ultrastruct Pathol; 2006; 30(1):95-102. PubMed ID: 16517475
[TBL] [Abstract][Full Text] [Related]
32. Soluble E-selectin in sera of patients with atopic dermatitis and psoriasis--correlation with disease activity.
Czech W; Schöpf E; Kapp A
Br J Dermatol; 1996 Jan; 134(1):17-21. PubMed ID: 8745880
[TBL] [Abstract][Full Text] [Related]
33. Bullous pemphigoid in a patient with psoriasis during the course of PUVA therapy: study by ELISA test.
Barnadas MA; Gilaberte M; Pujol R; Agustí M; Gelpí C; Alomar A
Int J Dermatol; 2006 Sep; 45(9):1089-92. PubMed ID: 16961518
[TBL] [Abstract][Full Text] [Related]
34. CD56brightCD16(-) NK cells accumulate in psoriatic skin in response to CXCL10 and CCL5 and exacerbate skin inflammation.
Ottaviani C; Nasorri F; Bedini C; de Pità O; Girolomoni G; Cavani A
Eur J Immunol; 2006 Jan; 36(1):118-28. PubMed ID: 16323244
[TBL] [Abstract][Full Text] [Related]
35. Deactivation of endothelium and reduction in angiogenesis in psoriatic skin and synovium by low dose infliximab therapy in combination with stable methotrexate therapy: a prospective single-centre study.
Goedkoop AY; Kraan MC; Picavet DI; de Rie MA; Teunissen MB; Bos JD; Tak PP
Arthritis Res Ther; 2004; 6(4):R326-34. PubMed ID: 15225368
[TBL] [Abstract][Full Text] [Related]
36. Downregulation of the inhibitor of apoptosis protein survivin in keratinocytes and endothelial cells in psoriasis skin following infliximab therapy.
Markham T; Mathews C; Rogers S; Mullan R; Bresnihan B; Fitzgerald O; Veale DJ; Fearon U
Br J Dermatol; 2006 Dec; 155(6):1191-6. PubMed ID: 17107388
[TBL] [Abstract][Full Text] [Related]
37. [Cutaneous lipids and psoriasis].
Vignale RA; Lasalvia E
Med Cutan Ibero Lat Am; 1983; 11(1):7-10. PubMed ID: 6348444
[TBL] [Abstract][Full Text] [Related]
38. The immune detection and quantitation of antigenic cell-free Fc receptor by solid phase RIA employing monoclonal anti FcR antibody.
Ran M; Dux Z; Anavi P; Witz IP
Dev Biol Stand; 1984; 57():367-70. PubMed ID: 6526145
[TBL] [Abstract][Full Text] [Related]
39. Activation of lymphocytes alters Fc receptor-beta 2-microglobulin interrelationship on the lymphocyte surface.
Sármay G; Gergely J
Cell Immunol; 1983 May; 78(1):73-82. PubMed ID: 6189625
[TBL] [Abstract][Full Text] [Related]
40. Advanced protein glycation in psoriasis.
Damasiewicz-Bodzek A; Wielkoszyński T
J Eur Acad Dermatol Venereol; 2012 Feb; 26(2):172-9. PubMed ID: 21395695
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
